SLS News and Press, SELLAS Life Sciences Group Inc. From 02/06/24

NEW YORK, Feb. 06, 2024 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS’’ or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer indications, today ...

NEW YORK, Jan. 25, 2024 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS” or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer indications, today announce...

VANCOUVER, British Columbia, Jan. 22, 2024 (GLOBE NEWSWIRE) -- Solaris Resources Inc . (TSX: SLS; OTCQB: SLSSF) (“Solaris” or the “Company”) is pleased to announce a corporate update including the commencement of the 2024 drilling program at its Warintza Project (&...

2024-01-11 07:24:34 ET Sellas Life Sciences ( NASDAQ: SLS ) shares jumped as much as 13% premarket on Thursday after the biopharmaceutical company and partner GenFleet Therapeutics disclosed yet another regulatory milestone for their CDK9 inhibitor, SLS009 (GFH009). The ther...

VANCOUVER, British Columbia, Jan. 11, 2024 (GLOBE NEWSWIRE) -- Solaris Resources Inc . (TSX: SLS; OTCQB: SLSSF) (“Solaris” or the “Company”) is pleased to announce that it has entered into a subscription agreement (the “Subscription Agreement”) in res...

2024-01-09 09:36:27 ET Sellas Life Sciences ( NASDAQ: SLS ) shares gained over 5% on Tuesday after the biopharmaceutical company received the U.S. Food and Drug Administration (FDA) fast track designation for its relapsed/refractory (r/r) acute myeloid leukemia (AML) treatme...

- Phase 2a Enrollment Completed in 45 mg Safety Cohort: Median Overall Survival (OS) Not Reached; 89% of Patients Alive with Significant Antileukemic Effect Observed in 87.5% of Evaluable Patients - - First Enrolled Patient in Phase 2a Study Achieved Complete Remission and Continues o...

VANCOUVER, British Columbia, Jan. 08, 2024 (GLOBE NEWSWIRE) -- Solaris Resources Inc . (TSX: SLS; OTCQB: SLSSF) (“Solaris” or the “Company”) is pleased to announce a preview of its 2024 plans for the Company and its Warintza Project (“Warintza” or &#x...

2024-01-04 09:22:39 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Peloton (NASDAQ: PTON ) stock is on the rise Thursday as investors celebrate a new partnership between the fitness company and TikTok . This partnership has Peloton sett...

2024-01-04 09:07:20 ET More on SELLAS Life Sciences SELLAS Life Sciences announces launch of proposed public offering SELLAS provides corporate updates, shares up premarket Seeking Alpha’s Quant Rating on SELLAS Life Sciences For further details see: ...